T0	Participants 99 136	patients with advanced heart failure.
T1	Participants 410 438	patients with heart failure.
T2	Participants 470 559	142 patients with symptomatic heart failure (New York Heart Association class III and IV)
T3	Participants 1543 1579	patients with advanced heart failure